Molecular Partners
MOLN
Molecular Partners (MOLN) news
Recent news
Molecular Partners AG: cash position of CHF 67.9 million as of June 30, 2026, expected to fund operations into late 2027
AInvest Wire · 6d agoMolecular Partners AG: Maintains previously reported FY forecast total operating expenses
Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN) has maintained its previously reported full-year 2025 forecast for total operating expenses, aligning with its guidance of CHF 55–65 million at constant exchange rates. The company’s 2025 Annual Report, published in March 2026, confirmed that…
AInvest Wire · 6d agoMolecular spikes 5% as the Co. to provide updates at 42nd annual JPM Healthcare conference
AInvest Wire · Jan 8, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.